QSAR and 3D QSAR in drug design Part 2: applications and problems
- 1 December 1997
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 2 (12) , 538-546
- https://doi.org/10.1016/s1359-6446(97)01084-2
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Recent Success Stories Leading to Commercializable Bioactive Compounds with the Aid of Traditional QSAR ProceduresQuantitative Structure-Activity Relationships, 1997
- Design principles for orally bioavailable drugsDrug Discovery Today, 1996
- 3D-QSAR: a current perspectiveTrends in Pharmacological Sciences, 1995
- Transition-state selectivity for a single hydroxyl group during catalysis by cytidine deaminaseBiochemistry, 1995
- Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property RelationshipsJournal of Chemical Information and Computer Sciences, 1994
- Recommendations for CoMFA Studies and 3D QSAR PublicationsQuantitative Structure-Activity Relationships, 1994
- Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR ProblemsQuantitative Structure-Activity Relationships, 1993
- Successes of Computer‐Assisted Molecular DesignPublished by Wiley ,1990
- Hydrophobicity and Central Nervous System Agents: On the Principle of Minimal Hydrophobicity in Drug DesignJournal of Pharmaceutical Sciences, 1987
- Model building in structure-activity relations. Reexamination of adrenergic blocking activity of .beta.-halo-.beta.-arylalkylaminesJournal of Medicinal Chemistry, 1973